Newsroom | 1537 results

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced new data from two implementation studies showing zero cases of HIV acquisition for Apretude, the only long-acting injectable approved for HIV prevention. Real-world data were also presented for Cabenuva, the only approved, complete long-acting injectable treatment regimen, showing its effectiveness in the three years since it has been avail...

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.1 The study found that N6LS (VH3810109 or VH109), given every four months in combination with monthly cabotegravir long-acting (CAB LA), successfully kept viral levels suppressed in adults living with HIV who were already stable on treatment. It was also well tolerated by particip...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Announces Data from Phase 3 Trials that Show Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir Maintained HIV-1 Viral Suppression...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment portfolio and pipeline at the Conference on Retroviruses and Opportunistic Infections (CROI 2025). The new findings reflect a transformative portfolio and a rapidly advancing forward-looking pipeline focused on expanding choices and enhancing outcomes for those with HIV, while continuing to reach towar...

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from two phase IIa proof-of-concept studies of investigational antiretroviral therapies VH4524184 (VH184) and VH4011499 (VH499). These findings, presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2025) in San Francisco, U.S., support the continued development of these two compounds as distinct o...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of lenacapavir, the company’s injectable HIV-1 capsid inhibitor, for the investigational use of HIV prevention as pre-exposure prophylaxis (PrEP). The data were presented during an oral abstract session at the Conference on Retroviruses and Opportunistic Infections (CROI 2025) and were also published today in T...

LOS ÁNGELES--(BUSINESS WIRE)--En este Día Internacional de la Mujer (DIM), que se celebra el 8 de marzo, la AIDS Healthcare Foundation (AHF) se solidariza con las mujeres y las niñas de todo el mundo, celebrando sus logros y defendiendo al mismo tiempo la acción para acabar con las barreras que obstaculizan la salud, la igualdad y las oportunidades. Este año, los equipos de AHF en todo el mundo se unen al movimiento global para exigir el fin de las desigualdades que frenan a las mujeres y las n...

LOS ANGELES--(BUSINESS WIRE)--Op deze Internationale Vrouwendag (IWD), die op 8 maart wordt gevierd, is de AIDS Healthcare Foundation (AHF) solidair met vrouwen en meisjes over de hele wereld. We vieren hun prestaties en voeren actie om de barrières op het gebied van gezondheid, gelijkheid en kansen weg te nemen. Dit jaar sluiten AHF-teams wereldwijd zich aan bij de wereldwijde beweging om een einde te eisen aan de ongelijkheden die vrouwen en meisjes tegenhouden. Wij doen dit met IWD-herdenkin...

LOS ANGELES--(BUSINESS WIRE)--On this International Women’s Day (IWD), observed on March 8, AIDS Healthcare Foundation (AHF) stands in solidarity with women and girls worldwide, celebrating their achievements while championing action to break down barriers to health, equality, and opportunity. This year, AHF teams worldwide are joining the global movement to demand an end to the inequities that hold women and girls back with IWD commemorations to remind everyone that when women and girls thrive...

MIAMI--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab and the Miami Center for AIDS Research, will cohost a webinar, "Reimagining HIV/AIDS Care: Strategies for the Next Generation,” on Thursday, March 6, 2025 at 12:00 PM EST, virtually via Zoom. Register here. This webinar will provide a comprehensive exploration of the future of HIV/AIDS care, examining key advancements in therapies, care models, and public health polic...